Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Monoclonal immunoglobulins promote bone loss in multiple myeloma

Marita Westhrin, Vlado Kovcic, Zejian Zhang, Siv H. Moen, Tonje Marie Vikene Nedal, Albert Bondt, Stephanie Holst, Kristine Misund, Glenn Buene, Anders Sundan, Anders Waage, Tobias S. Slørdahl, Manfred Wuhrer, Therese Standal

Blood (2020) 136 (23): 2656–2666.

https://doi.org/10.1182/blood.2020006045

Published: 2020

Includes: Supplemental data

Journal Articles

Glycosylationof Immunoglobulins Determine Bone Loss in Multiple Myeloma

Marita Westhrin, Vlado Kovcic, Albert Bondt, Stephanie Holst, Zejian Zhang, Anders Sundan, PhD, Tobias S. Slørdahl, Anders Waage, MD PhD, Manfred Wuhrer, Therese Standal

Blood (2019) 134 (Supplement_1): 4324.

https://doi.org/10.1182/blood-2019-122542

Published: 2019

Journal Articles

Whole-Exome and mRNA Sequencing of Multiple Myeloma Reveal Transformation to a More High-Risk and Proliferative Tumor at Relapse

Kristine Misund, PhD, Davine Hofste Op Bruinink, MD, Eivind Coward, PhD, Remco Hoogenboezem, MSc, Even H Rustad, MD, Eivind Hovig, PhD, Anders Sundan, PhD, Ola Myklebost, PhD, Pieter Sonneveld, MD PhD, Anders Waage, MD PhD

Blood (2018) 132 (Supplement 1): 3157.

https://doi.org/10.1182/blood-2018-99-113553

Published: 2018

Journal Articles

BMP4 Gene Therapy Inhibits Myeloma Tumor Growth, but Has a Negative Impact on Bone

Toril Holien, PhD, Marita Westhrin, PhD, Siv Helen Moen, PhD, Muhammad Zahoor, PhD, Glenn Buene, Berit Størdal, Hanne Hella, Huipin Yuan, Joost D de Bruijn, PhD, Anton Martens, PhD, Richard WJ Groen, PhD, Fatima Bosch, PhD, Ulf Smith, MD PhD, Anders Sundan, PhD, Therese Standal, PhD

Blood (2018) 132 (Supplement 1): 1928.

https://doi.org/10.1182/blood-2018-99-112429

Published: 2018

Journal Articles

A Gain-of-Function Mutation in EPO Gene Causes Familial Erythrocytosis

Jakub Zmajkovic, MS, Pontus Lundberg, PhD, Ronny Nienhold, PhD, Anders Sundan, PhD, Anders Waage, MD PhD, Radek C. Skoda, MD

Blood (2017) 130 (Supplement 1): 1653.

https://doi.org/10.1182/blood.V130.Suppl_1.1653.1653

Published: 2017

Journal Articles

Detection and Monitoring of BRAF and NRAS Mutant Clones in Myeloma Patients By Digital PCR of Circulating DNA

Even Holth Rustad, Hong Yan Dai, PhD, Eivind Coward, PhD, Kristine Misund, PhD, Anders Sundan, PhD, Anders Waage, MD PhD

Blood (2015) 126 (23): 4196.

https://doi.org/10.1182/blood.V126.23.4196.4196

Published: 2015

Journal Articles

Clinical and Biological Implications of BRAF V600E Mutation in Multiple Myeloma

Even Holth Rustad, Hong Yan Dai, PhD, Haakon Hov, MDPhD, Eivind Coward, PhD, Vidar Beisvag, PhD, Ola Myklebost, MDPhD, Eivind Hovig, PhD, Sigve Nakken, PhD, Daniel Vodák, Leonardo A Meza-Zepeda, PhD, Arne K Sandvik, MDPhD, Karin Fahl Wader, MD PhD, Kristine Misund, PhD, Anders Sundan, PhD, Harald Aarset, MDPhD, Anders Waage, MD PhD

Blood (2014) 124 (21): 5685.

https://doi.org/10.1182/blood.V124.21.5685.5685

Published: 2014

Journal Articles

A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells

Kristine Misund, PhD, Katarzyna Anna Baranowska, MD, Toril Holien, PhD, Christoph Rampa, MSc, Dionne Klein, PhD, Magne Børset, MD, PhD, Anders Waage, MD, PhD, Anders Sundan, PhD

Blood (2012) 120 (21): 1373.

https://doi.org/10.1182/blood.V120.21.1373.1373

Published: 2012

Journal Articles

Addiction to c-MYC in multiple myeloma

Toril Holien, Thea Kristin Våtsveen, Hanne Hella, Anders Waage, Anders Sundan

Blood (2012) 120 (12): 2450–2453.

https://doi.org/10.1182/blood-2011-08-371567

Published: 2012

Includes: Supplemental data

Journal Articles

Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells

Unn-Merete Fagerli, MD, PhD, Thorsten Stühmer, PhD, Toril Holien, Randi Utne Holt, PhD, Ove Bruland, PhD, Manik Chatterjee, MD, John Shaughnessy, Jr, PhD, Stephan Mathas, MD, Anders Sundan, MD, Ralf C Bargou, MD, Bernd Dörken, MD, Magne Borset, MD, PhD, Martin Janz, MD

Blood (2010) 116 (21): 1915.

https://doi.org/10.1182/blood.V116.21.1915.1915

Published: 2010

Journal Articles

OH-2, a Hyperdiploid Myeloma Cell Line without An IGH Translocation, Has a Complex Translocation Juxtaposing MYC near MAFB and the IGK Locus

Thea Kristin Våtsveen, Erming Tian, Stine H Kresse, Leonardo A Meza-zepeda, Ana Gabrea, Hong Yan Dai, Michael Kuehl, MD, Anders Sundan, Magne Borset, MD, PhD

Blood (2008) 112 (11): 2736.

https://doi.org/10.1182/blood.V112.11.2736.2736

Published: 2008

Journal Articles

Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells

Unn-Merete Fagerli, Randi U. Holt, Toril Holien, Thea K. Vaatsveen, Fenghuang Zhan, Kjartan W. Egeberg, Bart Barlogie, Anders Waage, Harald Aarset, Hong Yan Dai, John D. Shaughnessy, Jr, Anders Sundan, Magne Børset

Blood (2008) 111 (2): 806–815.

https://doi.org/10.1182/blood-2007-07-101139

Published: 2008

Journal Articles

IL-6 and IGF-1 Act in Synergy with HGF in Myeloma Cells by Modulating the Ras-MAPK Pathway.

Håkon Hov, MD, Erming Tian, BS, Anders Waage, MD, PhD, Magne Børset, MD, PhD, Anders Sundan, PhD

Blood (2007) 110 (11): 4793.

https://doi.org/10.1182/blood.V110.11.4793.4793

Published: 2007

Journal Articles

HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma

Therese Standal, Niels Abildgaard, Unn-Merete Fagerli, Berit Stordal, Øyvind Hjertner, Magne Borset, Anders Sundan

Blood (2006) 109 (7): 3024–3030.

https://doi.org/10.1182/blood-2006-07-034884

Published: 2006

Includes: Supplemental data

Journal Articles

Multiple Myeloma: Interleukin-15 Antagonizes Bone Morphogenetic Protein-Induced Apoptosis and Growth Inhibition.

Magne Rekvig, Anne-Tove Brenne, Torstein Baade Ro, Anders Waage, Magne Borset, Anders Sundan

Blood (2006) 108 (11): 3444.

https://doi.org/10.1182/blood.V108.11.3444.3444

Published: 2006

Journal Articles

HGF Inhibits BMP-Induced Osteoblastogenesis: Implications for the Bone Disease in Multiple Myeloma.

Therese Standal, Niels Abildgaard, Unn-Merete Fagerli, Berit Stordal, Oyvind Hjertner, Magne Borset, Anders Sundan

Blood (2006) 108 (11): 3451.

https://doi.org/10.1182/blood.V108.11.3451.3451

Published: 2006

Journal Articles

IL-6, IGF-1 and IL-21 Act in Synergy with HGF in Myeloma Cells by Inducing the HGF-Receptor c-Met.

Håkon Hov, MD, Unn-Merethe Fagerli, MD, Erming Tian, BS, Anders Waage, MD, PhD, Magne Borset, MD, PhD, Anders Sundan, PhD

Blood (2006) 108 (11): 3438.

https://doi.org/10.1182/blood.V108.11.3438.3438

Published: 2006

Journal Articles

Induction of Cyclin D1 by HGF, IGF-1 and IL-6 in a Human Myeloma Cell Line with a t(11:14) Translocation.

Håkon Hov, MD, Thea K. Våtsveen, Anders Waage, MD,PhD, Anders Sundan, MD,PhD, Magne Borset, MD,PhD

Blood (2006) 108 (11): 5055.

https://doi.org/10.1182/blood.V108.11.5055.5055

Published: 2006

Journal Articles

A Selective Inhibitor of c-Met Blocks an Autocrine HGF Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma Cells.

Magne Borset, M.D., Ph.D., Hakon Hov, M.D., Randi U. Holt, M.Sc., Torstein B. Ro, M.D., Unn-Merete Fagerli, M.D., Henrik Hjorth-Hansen, M.D., Ph.D., Vadim Baykov, M.D., Ph.D., James G. Christensen, Ph.D., Anders Waage, M.D., Ph.D., Anders Sundan, Ph.D.

Blood (2004) 104 (11): 2358.

https://doi.org/10.1182/blood.V104.11.2358.2358

Published: 2004

Journal Articles

Bmps(Bone Morphogenetic Proteins) Inhibit Growth in Multiple Myeloma Cells by p53 Activation.

Anders Sundan, PhD, Torstein B. Ro, MD, Janne Bonhorst, PhD, Anders Waage, MD, PhD, Magne Borset, MD, PhD

Blood (2004) 104 (11): 3354.

https://doi.org/10.1182/blood.V104.11.3354.3354

Published: 2004

NARROW

Monoclonal immunoglobulins promote bone loss in multiple myeloma

Glycosylationof Immunoglobulins Determine Bone Loss in Multiple Myeloma

Whole-Exome and mRNA Sequencing of Multiple Myeloma Reveal Transformation to a More High-Risk and Proliferative Tumor at Relapse

BMP4 Gene Therapy Inhibits Myeloma Tumor Growth, but Has a Negative Impact on Bone

A Gain-of-Function Mutation in EPO Gene Causes Familial Erythrocytosis

Detection and Monitoring of BRAF and NRAS Mutant Clones in Myeloma Patients By Digital PCR of Circulating DNA

Clinical and Biological Implications of BRAF V600E Mutation in Multiple Myeloma

A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells

Addiction to c-MYC in multiple myeloma

Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells

OH-2, a Hyperdiploid Myeloma Cell Line without An IGH Translocation, Has a Complex Translocation Juxtaposing MYC near MAFB and the IGK Locus

Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells

IL-6 and IGF-1 Act in Synergy with HGF in Myeloma Cells by Modulating the Ras-MAPK Pathway.

HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma

Multiple Myeloma: Interleukin-15 Antagonizes Bone Morphogenetic Protein-Induced Apoptosis and Growth Inhibition.

HGF Inhibits BMP-Induced Osteoblastogenesis: Implications for the Bone Disease in Multiple Myeloma.

IL-6, IGF-1 and IL-21 Act in Synergy with HGF in Myeloma Cells by Inducing the HGF-Receptor c-Met.

Induction of Cyclin D1 by HGF, IGF-1 and IL-6 in a Human Myeloma Cell Line with a t(11:14) Translocation.

A Selective Inhibitor of c-Met Blocks an Autocrine HGF Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma Cells.

Bmps(Bone Morphogenetic Proteins) Inhibit Growth in Multiple Myeloma Cells by p53 Activation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only